You are on page 1of 2

MAHAVIR ADVANCED REMEDIES LIMITED

(Formerly: Indo-American Advanced Pharmaceuticals Ltd.)


Regd. Office : No.91, D-11, Govindappa Naicken Street, Chennai 600 001
Rs. in Lacs
Statement of Un-Audited Results for the Quarter & Nine Months ended 31st December 2013

Particulars
Sr.
No.
1 Income from Operations
a) Net Sales/Income/(Loss) from Investing Activities
b) Other Operating Income
Total Income from Operations (Net)
2 Expenses
(a) Cost of Material Consumed
(b) Purchases of Stock-in-trade
(c) Changes in Inventories of Finished Goods, Work-in-Progress and Stock-in-Trade
(d) Employees Benefit Expenses
(e) Depreciation & Amortization Expenses
(f) Other Expenses
Total Expenses
3 Profit/(Loss) from Operations before other Income, finance cost and exceptional
Expenses (1-2)
4 Other Income/(Loss)
5 Profit/(Loss) from ordinary activities before finance costs and exceptional items
(3+4)
6 Finance Costs
7 Profit/(Loss) from ordinary activities after finance cost but before exceptional
items (3+4)
8 Exceptional Items
9 Profit(+)/Loss(-) from ordinary activites before Tax (7-8)
10 Tax Expenses
11 Net Profit (+)/Loss(-) from ordinary activites after tax (9-10)
Lac)
12 Extra Ordinary Items (Net of Tax Expense of Rs.
13 Net Profit (+)/Loss(-) for the period (11-12)
14 Share of Profit/(Loss) of Associates*
15 Minority Interest*
Net Profit (+)/Loss(-) after tax, minority interest and Share of Profit / (Loss) of
16 Associates (13-14-15)
17 Paid-up Equity Share Capital (Face Value of Rs. 10/- each)
18 Reserves excluding revaluation Reserves as per last Balance Sheet

3 Months
ended
31.12.2013

1.
2.
3.
4.

Corresponding 3
Months ended
31.12.2012

9 Months
Corresponding 9
ended
Months ended
31.12.2013
31.12.2012
Un-Audited

Year to date
figures as on
31.03.2013
Audited

2.78
2.78

2.62
2.62

1.20
1.20

7.90
7.90

12.06
12.06

13.65
0.84
14.49

0.30
0.64
0.94

0.30
0.44
0.74

1.05
1.05

0.90
2.12
3.02

0.64
10.80
11.44

6.20
12.53
18.73

1.84
-

1.88
-

0.15
-

4.88
-

0.62
-

(4.24)
-

1.84
-

1.88
-

0.15
-

4.88
-

0.62
-

(4.24)
-

1.84
1.84
1.84
1.84
-

1.88
4.07
(2.19)
(2.19)
(2.19)
-

0.15
0.15
0.15
0.15
-

4.88
4.07
0.81
0.81
0.81
-

0.62
11.07
(10.45)
(10.45)
(10.45)
-

(4.24)
11.07
(15.31)
(15.31)
(15.31)
-

1.84
1,135.92
-

(2.19)
1,135.92
-

0.15
500.92

0.81
1,135.92
-

(10.45)
500.92
-

(15.31)
500.92
(287.00)

0.02
0.02

(0.02)
(0.02)

0.00
0.00

0.04
0.04

(0.21)
(0.21)

(0.31)
(0.31)

0.02
0.02

(0.02)
(0.02)

0.00
0.00

0.01
0.01

(0.21)
(0.21)

(0.31)
(0.31)

19 Earning Per Share (before extra-ordinary items) of Rs. 10/- each (not annualized)
(i) a) Basic
b) Diluted
19 Earning Per Share (after extra-ordinary items) of Rs. 10/- each (not annualized)
(ii) a) Basic
b) Diluted
A PARTICULARS OF SHAREHOLDING
Public Shareholding
- Number of Shares
- Percentage of Share Holding
18 Promoter and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of Shares
- Percentage of Shares (as a % of the total Shareholding
of Promoter and Promoter Group
- Percentage of Shares (as a % of the total Share Capital of the Company
b) None-Encumbered
- Number of Shares
- Percentage of Shares (as a % of the total Shareholding
of Promoter and Promoter Group
- Percentage of Shares (as a % of the total Share Capital of the Company
B INVESTOR COMPLAINTS
Pending at the beginning of the Quarter
Received during the Quarter
Notes :

Preceding 3
Months ended
30.09.2013
Un-Audited

10,438,800

10,438,800

4,088,800

10,438,800

4,088,800

4,088,800

91.90

91.90

81.63

91.90

81.63

81.63

920,400
100.00

920,400
100.00

920,400
100.00

920,400
100.00

920,400
100.00

920,400
100.00

8.10

8.10

18.37

8.10

18.37

18.37

Nil
1

Disposed during the Quarter


Remaining Unresolved at the end of Quarter

Nil
1

Segmental Report for the Quarter as per AS-17 of ICAI is not applicable for the Quarter.
Above resultes were reviewed by Audit Committee taken on record in Board Meeting held on 14th February, 2014.
Provision for Taxation will be made at the end of the Financial Year.
The Statutory Auditors of the Company have carried out "Limited Review" of the above Financial Results.

Place : Chennai
Date : 14th February 2014

For MAHAVIR ADVANCED REMEDIES LIMITED


S/dB.V.S. KOTEESWARA RAO
Managing Director